Director Dennis Lam of HF Foods Group Inc. recently added to his personal stake in the company, according to a Form 4 filing with the Securities and Exchange Commission. The filing shows two purchases executed on March 18 and March 19, 2026, totaling 8,100 shares. Transaction prices ranged from $1.76 to $1.7966 per share, yielding an aggregate acquisition cost of $14,548.
The insider buying occurred while HF Foods shares were trading near $1.85. Over the previous six months the stock has fallen about 46% from earlier levels. Analysis cited alongside the filing places the stock at approximately 0.49 times book value and notes analyst price targets in the $6 to $7 range.
Those valuation metrics and price targets are mentioned in connection with a more detailed research package that includes 11 additional ProTips and comprehensive financial metrics available through the publisher's Pro research service. The filing does not detail whether Lam financed the purchase from exercise of options or from existing cash balances; it only reports the open-market transactions and their prices.
Separately, HF Foods reported results for the fourth quarter of 2025. The company recorded net revenue of $1.23 billion, a 2.2% increase versus the same quarter a year earlier. Management attributed the revenue uptick to higher volumes and pricing improvements across key categories, which the company said helped sustain steady financial performance despite challenging macroeconomic conditions.
Market observers have acknowledged the company’s ability to keep revenue growth intact in a tough environment, though the public record tied to the most recent filing and the earnings release does not show any contemporaneous analyst upgrades or downgrades. The combination of an insider purchase, modest top-line growth and deep valuation multiples presents a mixed signal for investors evaluating HF Foods’ near-term trajectory.
Context and implications
- Insider activity: The reported purchases are straightforward open-market buys totaling 8,100 shares for $14,548, executed over two days in March 2026.
- Valuation snapshot: The stock is presented as trading near 0.49 times book value, with analyst targets cited between $6 and $7 per share.
- Operational performance: Q4 2025 revenue rose 2.2% year-over-year to $1.23 billion, driven by volume and pricing gains in core categories.